• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

全身淋巴照射后对同种异体移植排斥反应和移植物抗宿主病的同时保护作用:自然杀伤T细胞的作用

Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.

作者信息

Liu Yin Ping, Li Zengqi, Nador Roland G, Strober Samuel

机构信息

Division of Immunology & Rheumatology, Department of Medicine, Stanford University School of Medicine, Stanford, CA 94305-5166, USA.

出版信息

Transplantation. 2008 Feb 27;85(4):607-14. doi: 10.1097/TP.0b013e31816361ce.

DOI:10.1097/TP.0b013e31816361ce
PMID:18347541
Abstract

BACKGROUND

The use of combined organ and bone marrow transplantation has been studied extensively in rodent models to induce immune tolerance to organ grafts. However, bone marrow transplants with mature donor T cells can induce graft-versus-host disease even in human leukocyte antigen-matched humans. We determined whether total lymphoid irradiation can simultaneously protect against graft-versus-host disease while facilitating tolerance.

METHODS

To more closely model clinical studies, we added mature donor T cells to bone marrow grafts combined with heart grafts, and compared murine graft and host survival after conditioning with nonmyeloablative total body or total lymphoid irradiation and depletive anti-T-cell antibodies.

RESULTS

Conditioning with total lymphoid irradiation protected hosts against both graft-versus-host disease and organ graft rejection. Although nonmyeloblative total body irradiation prevented organ graft rejection, all hosts succumbed to lethal graft-versus host disease. Induction of tolerance with total lymphoid irradiation and anti-T-cell antibodies was dependent on the presence of regulatory host natural killer T cells, and expression of CD1d on donor marrow but not heart graft cells.

CONCLUSION

Conditioning with total lymphoid irradiation and anti-T-cell antibodies prevented host-versus-donor and donor-versus-host alloimmune responses. Tolerance required host natural killer T-cell recognition of CD1d on donor marrow cells.

摘要

背景

在啮齿动物模型中,联合器官与骨髓移植已被广泛研究,以诱导对器官移植的免疫耐受。然而,即使在人类白细胞抗原匹配的个体中,含有成熟供体T细胞的骨髓移植也可诱发移植物抗宿主病。我们研究了全身淋巴照射是否能在促进耐受的同时预防移植物抗宿主病。

方法

为了更贴近临床研究,我们将成熟供体T细胞添加到与心脏移植相结合的骨髓移植中,并比较了在采用非清髓性全身照射或全身淋巴照射及去除性抗T细胞抗体进行预处理后小鼠移植物和宿主的存活情况。

结果

全身淋巴照射预处理可保护宿主免受移植物抗宿主病和器官移植排斥反应。虽然非清髓性全身照射可预防器官移植排斥反应,但所有宿主均死于致死性移植物抗宿主病。全身淋巴照射和抗T细胞抗体诱导的耐受依赖于调节性宿主自然杀伤T细胞的存在,以及供体骨髓而非心脏移植细胞上CD1d的表达。

结论

全身淋巴照射和抗T细胞抗体预处理可预防宿主抗供体和供体抗宿主同种免疫反应。耐受需要宿主自然杀伤T细胞识别供体骨髓细胞上的CD1d。

相似文献

1
Simultaneous protection against allograft rejection and graft-versus-host disease after total lymphoid irradiation: role of natural killer T cells.全身淋巴照射后对同种异体移植排斥反应和移植物抗宿主病的同时保护作用:自然杀伤T细胞的作用
Transplantation. 2008 Feb 27;85(4):607-14. doi: 10.1097/TP.0b013e31816361ce.
2
Protective conditioning against GVHD and graft rejection after combined organ and hematopoietic cell transplantation.联合器官与造血细胞移植后针对移植物抗宿主病和移植物排斥的保护性预处理。
Blood Cells Mol Dis. 2008 Jan-Feb;40(1):48-54. doi: 10.1016/j.bcmd.2007.06.019. Epub 2007 Sep 10.
3
Co-stimulated/Tc2 cells abrogate murine marrow graft rejection.共刺激/Tc2细胞消除小鼠骨髓移植排斥反应。
Biol Blood Marrow Transplant. 2004 Sep;10(9):604-13. doi: 10.1016/j.bbmt.2004.06.006.
4
Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells.通过全身淋巴照射和抗胸腺细胞球蛋白进行宿主预处理可预防移植物抗宿主病:CD1反应性自然杀伤T细胞的作用。
Biol Blood Marrow Transplant. 2003 Jun;9(6):355-63. doi: 10.1016/s1083-8791(03)00108-3.
5
Tolerance induction in a fully allogeneic combination using anti-T cell receptor-alpha beta monoclonal antibody, low dose irradiation, and donor bone marrow transfusion.使用抗T细胞受体αβ单克隆抗体、低剂量照射和供体骨髓输注在完全异基因组合中诱导耐受性。
Transplantation. 1995 Feb 15;59(3):395-401.
6
Facilitation of parental-strain marrow engraftment by T cells of neonatally-tolerant mice.新生期耐受小鼠的T细胞促进亲本品系骨髓移植
Biol Blood Marrow Transplant. 1997 Dec;3(6):294-303.
7
Suppression of graft-versus-host disease and amplification of graft-versus-tumor effects by activated natural killer cells after allogeneic bone marrow transplantation.异基因骨髓移植后活化自然杀伤细胞对移植物抗宿主病的抑制及对移植物抗肿瘤效应的增强
J Clin Invest. 1998 May 1;101(9):1835-42. doi: 10.1172/JCI1268.
8
Use of lymphokine-activated killer cells to prevent bone marrow graft rejection and lethal graft-vs-host disease.使用淋巴因子激活的杀伤细胞预防骨髓移植排斥和致死性移植物抗宿主病。
J Immunol. 1989 Sep 1;143(5):1524-9.
9
Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease.抗CD137单克隆抗体在易患慢性移植物抗宿主病的小鼠中诱导致死性移植物抗宿主病。
Biol Blood Marrow Transplant. 2009 Mar;15(3):306-14. doi: 10.1016/j.bbmt.2008.11.035.
10
FK506 inhibits graft-versus-host disease and bone marrow graft rejection in murine recipients of MHC disparate donor grafts by interfering with mature peripheral T cell expansion post-transplantation.FK506通过干扰移植后成熟外周T细胞的扩增,抑制MHC不相合供体移植物的小鼠受体中的移植物抗宿主病和骨髓移植排斥反应。
J Immunol. 1994 Aug 15;153(4):1836-46.

引用本文的文献

1
Establishment of Chimerism and Organ Transplant Tolerance in Laboratory Animals: Safety and Efficacy of Adaptation to Humans.嵌合体的建立与实验动物器官移植耐受:适应人体的安全性和有效性。
Front Immunol. 2022 Feb 10;13:805177. doi: 10.3389/fimmu.2022.805177. eCollection 2022.
2
Innate Immune Determinants of Graft-Versus-Host Disease and Bidirectional Immune Tolerance in Allogeneic Transplantation.同种异体移植中移植物抗宿主病和双向免疫耐受的固有免疫决定因素
OBM Transplant. 2019;3(1). doi: 10.21926/obm.transplant.1901044. Epub 2019 Jan 31.
3
Stable mixed chimerism and tolerance to human organ transplants.
稳定的混合嵌合体与对人类器官移植的耐受性。
Chimerism. 2015 Apr 3;6(1-2):27-32. doi: 10.1080/19381956.2015.1115584. Epub 2016 Feb 8.
4
Use of hematopoietic cell transplants to achieve tolerance in patients with solid organ transplants.使用造血细胞移植使实体器官移植患者实现免疫耐受。
Blood. 2016 Mar 24;127(12):1539-43. doi: 10.1182/blood-2015-12-685107. Epub 2016 Jan 21.
5
Path to clinical transplantation tolerance and prevention of graft-versus-host disease.临床移植耐受及移植物抗宿主病预防之路
Immunol Res. 2014 May;58(2-3):240-8. doi: 10.1007/s12026-014-8502-7.
6
Emerging concepts in haematopoietic cell transplantation.造血细胞移植中的新观点。
Nat Rev Immunol. 2012 May 25;12(6):403-16. doi: 10.1038/nri3226.
7
Translational studies in hematopoietic cell transplantation: treatment of hematologic malignancies as a stepping stone to tolerance induction.造血细胞移植中的转化研究:以血液系统恶性肿瘤治疗为诱导耐受的踏脚石。
Semin Immunol. 2011 Aug;23(4):273-81. doi: 10.1016/j.smim.2011.05.001. Epub 2011 Jun 25.
8
NKT cells, Treg, and their interactions in bone marrow transplantation.自然杀伤 T 细胞、调节性 T 细胞及其在骨髓移植中的相互作用。
Eur J Immunol. 2010 Jul;40(7):1862-9. doi: 10.1002/eji.201040394.